Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chang Yao
Institutions:
Nanjing University of Chinese Medicine,
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Observed institutions:
Nanjing University of Chinese Medicine,
Jiangsu Provincial Hospital of Traditional Chinese Medicine
ORCID:
0000-0002-4392-7207
Observed ORCID:
0000-0002-4392-7207
OpenAlex ID:
A5101616217
Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway
2019
·
Xiao‐Qing Zhang
, Chang Yao
, et al.
·
Food Science & Nutrition
·
36
PDF
Acupuncture for hot flashes in hormone receptor‐positive breast cancer: A pooled analysis of individual patient data from parallel randomized trials
2024
·
Weidong Lu
, Anita Giobbie‐Hurder
, et al.
·
Cancer
·
20
PDF
Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer
2024
·
Shiyi Yu
, Rui Wu
, et al.
·
Oncogene
·
17
Sanhuang Decoction Controls Tumor Microenvironment by Ameliorating Chronic Stress in Breast Cancer: A Report of Ninety Cases
2021
·
Ming Feng
, Huanhuan Wang
, et al.
·
Frontiers in Oncology
·
10
PDF
Acupuncture for hot flashes in hormone receptor-positive breast cancer, a coordinated multinational study: Rationale and design of the study protocol
2022
·
Weidong Lu
, Anita Giobbie-Hurder
, et al.
·
Contemporary Clinical Trials
·
7
Developing and implementing a self-monitoring toolkit for a coordinated multinational randomized acupuncture trial
2022
·
Sylvia Baedorf Kassis
, Weidong Lu
, et al.
·
BMC Complementary Medicine and Therapies
·
4
PDF
Construction of a novel disulfidptosis-associated lncRNAs signature for risk features and immunotherapy in breast cancer
2025
·
Jun Zhou
, Yongfei Li
, et al.
·
Translational Cancer Research
·
2
Trastuzumab Deruxtecan (DS8201) Rescue Advanced Her2 Low Expression Breast Cancer: A Case Report and Review of Literature
2024
·
Wenhao Mao
, Chang Yao
·
Journal of Contemporary Medical Practice
·
1
Inhibition of breast cancer cell invasion and epithelial – mesenchymal transition by Sanhuang decoction through the downregulation of CXCL8 secretion from mesenchymal stem cells
2024
·
Yu-tong Bai
, Wen-hao Mao
, et al.
·
Asian Journal of Surgery
·
1
Demethoxycurcumin inhibits breast cancer vascular remodeling through RGS5 to delay the progression of breast cancer
2026
·
Jie Chen
, Fangling Zhou
, et al.
·
Translational Oncology
Correction: miR-548as-5p promotes breast cancer cell apoptosis and improves tamoxifen resistance by downregulating NF-κB1
2026
·
Xu Chen
, Meng Tao
, et al.
·
Molecular Biology Reports
miR-548as-5p promotes breast cancer cell apoptosis and improves tamoxifen resistance by downregulating NF-κB1
2026
·
Xu Chen
, Meng Tao
, et al.
·
Molecular Biology Reports
Endocrine regimen and early subclinical atherosclerosis in premenopausal HR+/HER2− breast cancer: real-world evidence and regimen-dependent effects of Sanhuang Decoction
2026
·
Ke Hong
, Cong Wang
, et al.
·
Frontiers in Oncology
PDF
Shenmai injection in treating chemotherapy-related cardiotoxicity of breast cancer: a systematic review and meta-analysis
2024
·
Ming Feng
, Hong Huang
, et al.
·
Journal of Herbal Medicine
The experimental study of Sanhuang antioxidant decoction based on Nrf - 2 /ARE pathway in order to inhibiting angiogenesis of breast cancer cell
2016
·
Zhang Xiao-qing
, Bian Weihe
, et al.
·
Lishizhen Medicine and Materia Medica Research
Show more works
View as search
Works count:
15
Citation count:
98
H-index:
5
I10-index:
4
Year
Topic
Type